Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2022 - 04 - 12 save search
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-12 (Crawled : 22:00) - biospace.com/
ORIC | $9.2 -3.26% -3.37% 670K
|
Health Technology
|
| O: 2.81%
H: 3.57%
C: -2.73%
research preclinical cancer pre-clinical
BriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-12 (Crawled : 21:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 11.0%
H: 2.27%
C: -17.91%
research technology cancer platform
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting
Published: 2022-04-12 (Crawled : 20:00) - globenewswire.com
BPTH | News 0 d | $4.17 -0.71% -0.96% 2.1M
|
Health Technology
|
| O: -11.44%
H: 3.08%
C: -6.31%
bp1003 research cancer
Qualigen Therapeutics Presents Three Posters of QN-302 at American Association of Cancer Research Conference
Published: 2022-04-12 (Crawled : 14:20) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
|
| O: -4.43%
H: 160.94%
C: 59.11%
qn-302 research conference therapeutics cancer
Panbela Announces Poster Presentation at American Association for Cancer Research:The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancer
Published: 2022-04-12 (Crawled : 13:20) - biospace.com/
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 1.8%
H: 9.72%
C: -8.14%
sbp-101 presentation potential cancer ovarian cancer
LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations
Published: 2022-04-12 (Crawled : 13:20) - biospace.com/
LIXT | $3.351 4.68% 11K
|
Health Technology
|
| O: 127.27%
H: 98.0%
C: -26.4%
lb-100 netherlands drug preclinical collaboration results cancer pre-clinical
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
MTEM | $1.455 -2.02% -2.06% 13K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.46%
research potential molecular cancer
APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 0.0%
H: 14.99%
C: 4.04%
apvo442 research cancer prostate cancer
Nascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal Antibody
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
NBIO | $0.0924 15.32% 450
|
|
| O: -10.0%
H: 11.11%
C: 7.6%
antibody biotech unique order cancer
Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting
Published: 2022-04-12 (Crawled : 12:20) - biospace.com/
SDGR | $24.31 -0.12% -0.12% 600K
|
Technology Services
|
| O: 2.79%
H: 4.77%
C: -2.34%
research preclinical program cancer pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.